URS Corporation R&D Expense
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
None selected
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
URS R&D Expense Range, Past 5 Years
| Minimum | 0.00 | Mar 1987 |
| Maximum | 0.00 | Mar 1987 |
| Average |
About R&D Expense
R&D expenses are a line item from many companies' income statements.
R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.
Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.
An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
Learn More
You may also be interested in these URS related companies
URS News
Cup with handle galore this am. This ones trigger is 43.34 $URS http://chart.ly/8q3kyrc
about a day ago by chartsmart
about a day ago by chartsmart
Handles forming on these cup bases currently $URS $STLD $FSL $CVE $MENT http://stks.co/2JyW
about 4 days ago by chartsmart
about 4 days ago by chartsmart
URS Corporation to Host Conference Call to Discuss 2011 Fourth Quarter and Year-End Results
Feb 06, 8:30AM Business Wire
Feb 06, 8:30AM Business Wire
$FLR $FWLT $URS ....infrastructure stocks...cities and co's just need funding to Build...
about 39 days ago by EXPstocktrader
about 39 days ago by EXPstocktrader
Tuesday Pre-Market News (11/22/11) http://stks.co/1EUA $C $NFLX $HPQ $URS $GS $XLF $IYF $SPY
about 83 days ago by valuewalk
about 83 days ago by valuewalk
Glenview Capital Management reports 5.21% passive stake in URS Corporation
Nov 21, 4:27PM FlyOnTheWall
Nov 21, 4:27PM FlyOnTheWall
URS To Participate in the Robert W. Baird & Co. 2011 Clean Technology Conference
Nov 16, 8:30AM Business Wire
Nov 16, 8:30AM Business Wire
$URS URS Reports Q3 EPS $0.98 vs $0.99 Est; Revenues $2.47B vs $2.57B Est
about 96 days ago by Benzinga
about 96 days ago by Benzinga
$URS looks vulnerable here as it sits right on the 50d. Incr volume on the pullback leans me bearish on this one.
about 214 days ago by 1nvestor
about 214 days ago by 1nvestor
$URS http://chart.ly/q4vkjeg Weekly. TL test in progress, lets see if has what it takes this coming week.
about 217 days ago by 1nvestor
about 217 days ago by 1nvestor
URS Corp Reports EPS of $0.66 vs. $0.84 Estimate; Revenues $2.32B vs. $2.42B Estimate $URS
about 278 days ago by Benzinga
about 278 days ago by Benzinga
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| URS | 42.51 | 0.43 | 1.02% | 3.38B |
| ITRI | 41.45 | -0.96 | -2.28% | 1.69B |
| OEH | 8.68 | -0.27 | -3.02% | 890.65M |
| ABAX | 27.49 | -0.41 | -1.47% | 595.98M |
| PEGA | 29.46 | -0.17 | -0.57% | 1.11B |
| LOPE | 17.71 | 0.24 | 1.37% | 784.38M |
| WDC | 38.57 | -0.62 | -1.58% | 9.02B |
| DV | 38.56 | -0.28 | -0.72% | 2.59B |
| FALC | 2.77 | -0.08 | -2.81% | 129.39M |
| IMAX | 21.22 | -0.38 | -1.76% | 1.37B |
